BioMarin Pharmaceutical (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "BioMarin Pharmaceutical" in English language version.

refsWebsite

Global rank English rank

8web.archive.org

1^st place

3bizjournals.com

407^th place

241^st place

2sec.gov

572^nd place

436^th place

2bmrn.com

low place

1biomarin.com

low place

1reuters.com

49^th place

47^th place

1quotemedia.com

low place

1youtube.com

9^th place

13^th place

1ghostarchive.org

32^nd place

21^st place

1headtopics.com

low place

1biotechhistory.org

low place

1lexpert.ca

low place

1northbaybusinessjournal.com

low place

1thepharmaletter.com

low place

1morningstar.ca

low place

1genengnews.com

low place

6,625^th place

1siliconrepublic.com

low place

1nytimes.com

7^th place

1bbc.co.uk

8^th place

10^th place

1bmj.com

1,226^th place

1,421^st place

1doi.org

2^nd place

1nih.gov

4^th place

1semanticscholar.org

11^th place

8^th place

1huffingtonpost.com

109^th place

87^th place

1cnn.com

28^th place

26^th place

1pharmalive.com

low place

1br.de

1,260^th place

6,225^th place

1bbc.com

20^th place

30^th place

1tijd.be

8,096^th place

low place

bbc.co.uk

Goldberg, Adrian (2010-11-21). "Drug firms accused of exploiting loophole for profit". BBC News. Retrieved 2010-11-21.

bbc.com

"I helped test a wonder drug - then I was denied it". 2019-04-17. Retrieved 2019-04-18.

biomarin.com

"Leadership Team". Biomarin. Retrieved 5 December 2023.

biotechhistory.org

"BioMarin". Life Sciences at CHF. Archived from the original on 2016-03-23. Retrieved 2016-07-09.

bizjournals.com

Brown, Steven E.F. (2010-02-04). "BioMarin to buy Lead Therapeutics for $18M". San Francisco Business Times. Archived from the original on 2011-06-29. Retrieved 2014-02-18.
Leuty, Ron (2010-08-17). "BioMarin to buy ZyStor for up to $115M". San Francisco Business Times. Archived from the original on 2011-06-29. Retrieved 2014-02-18.
Brown, Steven (2013-01-07). "BioMarin Pharmaceutical buys Zacharon for $10 million". San Francisco Business Times. Retrieved 2013-01-07.

bmj.com

Hawkes, N.; Cohen, D. (2010-11-10). "What makes an orphan drug?". BMJ. 341. British Medical Journal: c6459. doi:10.1136/bmj.c6459. PMID 21081607. S2CID 2486975. Retrieved 2010-11-21.

bmrn.com

investors.bmrn.com

"BioMarin Announces Withdrawal of Market Authorization Application for Kyndrisa™ (drisapersen) in Europe (NASDAQ:BMRN)". investors.bmrn.com. Archived from the original on 2016-06-04. Retrieved 2016-07-04.

bmrn.com

BioMarin Office Site: Products

br.de

"Hannahs Kampf gegen Pharmafirma". B5 aktuell. 2015-05-13. Retrieved 2015-05-13.

cnn.com

"In cancer drug battle, both sides appeal to ethics". CNN. 2013-09-20. Retrieved 2013-12-24.

doi.org

Hawkes, N.; Cohen, D. (2010-11-10). "What makes an orphan drug?". BMJ. 341. British Medical Journal: c6459. doi:10.1136/bmj.c6459. PMID 21081607. S2CID 2486975. Retrieved 2010-11-21.

genengnews.com

"BioMarin to Acquire Prosensa for Up to $840M". GEN - Genetic Engineering and Biotechnology News. 2014-11-24. Retrieved 2020-07-03.

ghostarchive.org

BruceCockburnVEVO (2011-12-15), Bruce Cockburn - Call It Democracy, archived from the original on 2021-12-19, retrieved 2019-04-18

headtopics.com

"'A wonder drug helped me eat - then I had to go without'". 17 April 2019.

huffingtonpost.com

"Andrea Sloan Faces Pharma Firm With History Of Indifference". Huffington Post. 2013-09-26. Retrieved 2013-12-24.

lexpert.ca

"BioMarin Pharmaceutical Acquires Glyko Biomedical". Deals. LEXPERT. Thomson Reuters. January 2003. Archived from the original on 2013-12-28.

morningstar.ca

torontostar.morningstar.ca

Andersen, Karen (2010-10-21). "BioMarin Highlights Diverse Early-Stage Pipeline at R&D Day". Morningstar. Archived from the original on 2011-07-06. Retrieved 2011-02-14.

nih.gov

pubmed.ncbi.nlm.nih.gov

Hawkes, N.; Cohen, D. (2010-11-10). "What makes an orphan drug?". BMJ. 341. British Medical Journal: c6459. doi:10.1136/bmj.c6459. PMID 21081607. S2CID 2486975. Retrieved 2010-11-21.

northbaybusinessjournal.com

Stevens, Loralee (2009-10-27). "BioMarin Acquires Huxley Pharmaceuticals". North Bay Business Journal. Santa Rosa, California, United States. Archived from the original on 2011-01-04. Retrieved 2014-02-18.

nytimes.com

Pollack, A (2007-12-14). "Agency Approves Drug to Treat Genetic Disorder That Can Lead to Retardation". The New York Times. Retrieved 2008-04-03.

pharmalive.com

Ed Silverman for Pharmalot. October 4, 2013 Andrea Sloan, 'Poster Child' For Compassionate Use, Gets A Drug Archived 2013-12-28 at the Wayback Machine

quotemedia.com

app.quotemedia.com

"BioMarin Pharmaceutical Inc. 2020 Annual Report". app.quotemedia.com. 31 December 2020. Retrieved 20 November 2021.

reuters.com

"Biomarin Pharmaceutical Inc". reuters. Retrieved August 30, 2024.

sec.gov

"US SEC: Form 10-K BioMarin Pharmaceutical Inc". U.S. Securities and Exchange Commission. Retrieved March 31, 2018.
"Form S-1 Registration Statement". Biomarin Pharmaceuticals Inc. Retrieved 15 December 2015.

semanticscholar.org

api.semanticscholar.org

Hawkes, N.; Cohen, D. (2010-11-10). "What makes an orphan drug?". BMJ. 341. British Medical Journal: c6459. doi:10.1136/bmj.c6459. PMID 21081607. S2CID 2486975. Retrieved 2010-11-21.

siliconrepublic.com

Earley, Kelly (2019-10-02). "BioMarin opens new Dublin office to support EMEA growth". Silicon Republic. Retrieved 2019-10-07.

thepharmaletter.com

"BioMarin launches LEMS drug Firdapse in European Union; and Genmab gets conditional approval for Arzerra". The Pharma Letter. 2010-04-20. Retrieved 2014-02-18.(subscription required)

tijd.be

"BioMarin moet verder levensreddend middel leveren aan patiënte" [BioMarin must continue to provide life-saving drug to patient]. www.tijd.be (in Dutch). De Tijd. 26 June 2019. Retrieved 26 June 2019.

web.archive.org

"BioMarin". Life Sciences at CHF. Archived from the original on 2016-03-23. Retrieved 2016-07-09.
"BioMarin Pharmaceutical Acquires Glyko Biomedical". Deals. LEXPERT. Thomson Reuters. January 2003. Archived from the original on 2013-12-28.
Stevens, Loralee (2009-10-27). "BioMarin Acquires Huxley Pharmaceuticals". North Bay Business Journal. Santa Rosa, California, United States. Archived from the original on 2011-01-04. Retrieved 2014-02-18.
Brown, Steven E.F. (2010-02-04). "BioMarin to buy Lead Therapeutics for $18M". San Francisco Business Times. Archived from the original on 2011-06-29. Retrieved 2014-02-18.
Leuty, Ron (2010-08-17). "BioMarin to buy ZyStor for up to $115M". San Francisco Business Times. Archived from the original on 2011-06-29. Retrieved 2014-02-18.
Andersen, Karen (2010-10-21). "BioMarin Highlights Diverse Early-Stage Pipeline at R&D Day". Morningstar. Archived from the original on 2011-07-06. Retrieved 2011-02-14.
"BioMarin Announces Withdrawal of Market Authorization Application for Kyndrisa™ (drisapersen) in Europe (NASDAQ:BMRN)". investors.bmrn.com. Archived from the original on 2016-06-04. Retrieved 2016-07-04.
Ed Silverman for Pharmalot. October 4, 2013 Andrea Sloan, 'Poster Child' For Compassionate Use, Gets A Drug Archived 2013-12-28 at the Wayback Machine

youtube.com

BruceCockburnVEVO (2011-12-15), Bruce Cockburn - Call It Democracy, archived from the original on 2021-12-19, retrieved 2019-04-18